Evaluation of palartability of gummi drugscontained aripiprazole, epinastine, and ibpurofen

Evaluation of palartability of gummi drugscontained aripiprazole, epinastine, and ibpurofen - Evaluation of palartability of gummi drugs.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022589

Enrollment

Registered

2016-06-03

Start date

2015-10-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

Gummi drugs without flavours Gummi drugs with flavour A Gummi drugs with flavour B Gummi drugs with flavour A and flavour B Gummi drugs with flavour C Gummi drugs with menthorl Gummi drugs with flavor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy adults (female and male) aged >=20 years old

Exclusion criteria

Exclusion criteria: 1. clear taste disturbance 2. allegy for drugs 3. allegy for gelatin 4. pregnant woman and/or woman during lactation 5. Others who were decided as irrelevant by doctor

Design outcomes

Primary

Measure	Time frame
1.palatability (visual analogue scale) in mouth. 2.palatability (visual analogue scale) after spatting out	—

Countries

Japan

Contacts

Public ContactAkio Hakamata

Hamamatsu University School of Medicine Department of Clinical Pharmacology & Therapeutics

hakamata@hama-med.ac.jp053-435-2385

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026